Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Roche describes new inhibitors of MDM2/p53 interaction with utility in cancer

July 16, 2003

Low response rate for SU-5416 in refractory myeloproliferative disorders

July 16, 2003

FDA clears phase I study of PHP as an adjunct to IL-2 cancer therapy

July 15, 2003

Encouraging results from ongoing phase I/II trial with MetXia in breast cancer

July 15, 2003

Synthetic Hsp90 ATPase inhibitor identified as potential new lead anticancer agent

July 15, 2003

VEGF receptor tyrosine kinase inhibitor E-7080, a promising agent for solid tumors

July 15, 2003

Efaproxiral reported to improve survival in cancer patients with brain metastases

July 15, 2003

Further preclinical characterization of AG-013736, a VEGFR/PDGFR TK inhibitor

July 15, 2003

Orally available Src tyrosine kinase inhibitor characterized in vitro and in vivo

July 15, 2003

Roche presents new series of antitumor agents targeting CDK2

July 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...